Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Battaglin

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Journal of Cancer Metastasis and Treatment|September 17, 2021
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectivesFrancesca Battaglin, Alberto Puccini, Madiha Naseem, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 24, 2017
Colorectal cancer: epigenetic alterations and their clinical implicationsAlberto Puccini, Martin D Berger, Madiha Naseem, et al.
Cancer Treatment Reviews|April 10, 2018
Outlooks on Epstein-Barr virus associated gastric cancerMadiha Naseem, Afsaneh Barzi, Christine Brezden-Masley, et al.
The Oncologist|December 19, 2019
Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal CancerMohamed E Salem, Francesca Battaglin, Richard M Goldberg, et al.
Acta Oncologica (Stockholm, Sweden)|July 18, 2017
Angiogenesis inhibitors and symptomatic anal ulcers in metastatic colorectal cancer patients <sup>*</sup>Francesca Bergamo, Sara Lonardi, Beatrice Salmaso, et al.
Cancers|August 29, 2024
Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive ReviewKaram Ashouri, Alexandra Wong, Pooja Mittal, et al.
Oncogene|April 13, 2021
Clocking cancer: the circadian clock as a target in cancer therapyFrancesca Battaglin, Priscilla Chan, Yuanzhong Pan, et al.
British Journal of Cancer|October 24, 2021
Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancerHiroyuki Arai, Yi Xiao, Joshua Millstein, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancerHiroyuki Arai, Joshua Millstein, Fotios Loupakis, et al.
Eclinicalmedicine|February 23, 2023
Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trialsJingyuan Wang, Joshua Millstein, Yan Yang, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Journal of Cancer Metastasis and Treatment|September 17, 2021
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectivesFrancesca Battaglin, Alberto Puccini, Madiha Naseem, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 24, 2017
Colorectal cancer: epigenetic alterations and their clinical implicationsAlberto Puccini, Martin D Berger, Madiha Naseem, et al.
Cancer Treatment Reviews|April 10, 2018
Outlooks on Epstein-Barr virus associated gastric cancerMadiha Naseem, Afsaneh Barzi, Christine Brezden-Masley, et al.
The Oncologist|December 19, 2019
Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal CancerMohamed E Salem, Francesca Battaglin, Richard M Goldberg, et al.
Acta Oncologica (Stockholm, Sweden)|July 18, 2017
Angiogenesis inhibitors and symptomatic anal ulcers in metastatic colorectal cancer patients <sup>*</sup>Francesca Bergamo, Sara Lonardi, Beatrice Salmaso, et al.
Cancers|August 29, 2024
Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive ReviewKaram Ashouri, Alexandra Wong, Pooja Mittal, et al.
Oncogene|April 13, 2021
Clocking cancer: the circadian clock as a target in cancer therapyFrancesca Battaglin, Priscilla Chan, Yuanzhong Pan, et al.
British Journal of Cancer|October 24, 2021
Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancerHiroyuki Arai, Yi Xiao, Joshua Millstein, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancerHiroyuki Arai, Joshua Millstein, Fotios Loupakis, et al.
Eclinicalmedicine|February 23, 2023
Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trialsJingyuan Wang, Joshua Millstein, Yan Yang, et al.
Pageof 9